The fifth annual summit was UCSF-Stanford CERSI’s largest in-person meeting yet, showcasing the School’s commitment to the dynamic field of regulatory science in discussions with FDA center directors and past and present FDA commissioners.
Johnny Matheny demonstrates how a modular prosthetic limb works during DARPA Demo Day 2016 at the Pentagon, May 11, 2016. Matheny is a test subject with the Johns Hopkins Applied Physics Lab.
The patient perspective on prosthetic limbs currently doesn’t factor into the FDA approval process. Leslie Wilson and Matthew Garibaldi are surveying patient preferences to speed access to the next generation of prosthetics.
The U.S. Food and Drug Administration has awarded the UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (UCSF-Stanford CERSI) a five-year grant with up to $25 million in funding.
Healing Hands: Pharmacist Janel Boyle, PharmD, PhD (far left), who is developing dosing models tailored for children, comforts a young patient with her mother in the infusion clinic at UCSF Benioff Children’s Hospital San Francisco.
Reprinted courtesy of UCSF Magazine.
In the pediatric bone marrow transplant clinic, pharmacist Janel Boyle’s past and present collide.
She drifts past young patients—many of them infants and toddlers—and notes their beaming smiles and balding heads. Her gaze shifts to the parents, their...
The research journey toward building a fully functioning, surgically implantable artificial kidney as an alternative to kidney transplant and dialysis just took another step forward with the announcement of a $6 million grant to The Kidney Project, headquartered at the UCSF School of Pharmacy.
The U.S. Food and Drug Administration (FDA) is tapping the UCSF School of Pharmacy and Stanford University to launch its first West Coast regulatory science center, focused on spurring innovation in the development and evaluation of safer and more effective medications.
